Can a patient who has not required basal insulin be discharged on rapid‑acting insulin alone, using carbohydrate counting and correction factors?

No, Discharging on Rapid-Acting Insulin Alone is Strongly Discouraged

Prolonged use of correction or supplemental insulin without basal insulin is strongly discouraged in the inpatient setting, with the exception of patients with type 2 diabetes in noncritical care with mild hyperglycemia or stress hyperglycemia 1. This guideline directly addresses your question and provides clear direction.

Clinical Decision Framework

For Type 2 Diabetes Patients

The decision depends on the severity of hyperglycemia and home insulin requirements:

Mild Hyperglycemia (BG <200 mg/dL):

• If the patient was insulin-naive at home or on very low doses
• If HbA1c on admission was low
• Then: Correction doses with rapid-acting insulin alone may be acceptable 2
• Consider adding low-dose basal insulin (0.1 U/kg/day) or DPP-4 inhibitor for better control 2

Moderate to Severe Hyperglycemia:

• BG 201-300 mg/dL: Requires basal insulin at 0.2-0.3 U/kg/day with correction doses 2
• BG >300 mg/dL: Requires basal-bolus regimen 2

For Type 1 Diabetes Patients

Basal insulin is absolutely mandatory - even if the patient is taking nothing by mouth 1. Dosing insulin based solely on premeal glucose levels without basal insulin increases the risk of both hypoglycemia and hyperglycemia 1. Policies should ensure basal insulin is never held during care transitions 1.

Evidence on Rapid-Acting Insulin Monotherapy

Research shows approximately 50% of type 2 diabetes patients achieved adequate fasting glucose control (<120 mg/dL) with mealtime rapid-acting insulin alone 3. However, this was in a controlled study setting, not real-world discharge planning. Notably, all patients previously treated with sulfonylureas required basal insulin replacement 3.

Carbohydrate Counting Considerations

While carbohydrate counting with mealtime insulin is theoretically appealing, the evidence shows:

• Similar glycemic outcomes compared to fixed mealtime dosing 4, 5
• Greater rates of preprandial hypoglycemia (up to 8.6% vs 1.5%) 4
• Wide variability in actual carbohydrate intake (26-72g per meal) makes dosing unpredictable 5

Critical Pitfalls to Avoid

1. Never discharge type 1 diabetes patients without basal insulin - this is non-negotiable
2. Assess home insulin requirements - patients on sulfonylureas or high insulin doses (>0.6 U/kg/day) at home will need basal insulin 2, 3
3. Consider preoperative HbA1c - patients with HbA1c >9% are more likely to require basal insulin 6
4. Hypoglycemia risk - correction-only regimens increase morning hypoglycemia risk 4

Recommended Discharge Strategy

For the patient who hasn't needed basal insulin during hospitalization:

• If type 2 diabetes with mild hyperglycemia (<200 mg/dL) and insulin-naive: Consider discharge on correction insulin alone OR low-dose basal (0.1 U/kg/day) plus correction 2, 1
• If any other scenario: Discharge on basal-bolus regimen with the basal dose reduced by approximately 61% from any preoperative dose 6, or start at 0.2-0.3 U/kg/day 2
• Ensure 2-week follow-up for dose adjustment 6

The safest approach is to include at least low-dose basal insulin at discharge rather than relying solely on correction doses, as this reduces the risk of rebound hyperglycemia and provides more physiologic insulin replacement.